Direct Medical Expenditure and Healthcare Utilization with Mental Disorders among Hispanic Population using Medical Expenditure Panel Survey 2013-2017

2021 ◽  
Vol 9 (1) ◽  
pp. 10-17
Author(s):  
Jongwha Chang ◽  
◽  
Jangkwon Cho ◽  
Mar Medina ◽  
Jihaeng Heo ◽  
...  
Keyword(s):  
Mental Disorders ◽  
Healthcare Utilization ◽  
Medical Expenditure Panel Survey ◽  
Medical Expenditure ◽  
Hispanic Population ◽  
Panel Survey

scholarly journals Factors associated with Health-Related Quality of Life in Hispanic population with mental disorders using medical expenditure panel survey 2013-2017

2021 ◽  
Vol 10 (3) ◽  
pp. 1
Author(s):  
Jongwha Chang ◽  
Jangkwon Cho ◽  
Mar Medina ◽  
Stephanie Falcon ◽  
Paulina Soto-Ruiz ◽  
...  
Keyword(s):  
Mental Disorders ◽  
Medical Expenditure Panel Survey ◽  
Medical Expenditure ◽  
Panel Survey ◽  
Health Related Quality ◽  
Composite Scale ◽  
Hispanic Patients ◽  
Related Quality ◽  
Health Related

There is a lack of U.S. population-based research surrounding the marked decrease in health-related quality of life (HRQoL) caused by the morbidity of mental disorders in the U.S. Hispanic demographic. This cross-sectional study utilized data from the 2013-2017 Medical Expenditure Panel Survey (MEPS) to identify Hispanic community-dwelling residents with mental disorders in the U.S. The independent variable was the presence of mental disorders, and the dependent variable was HRQoL. HRQoL was measured with the Short Form 12 (SF-12) Physical Health Composite Scale (PCS) and Mental Health Composite Scale (MCS). A total of 34,434 patients met the inclusion criteria, representing about 38,683,299 Hispanic individuals. Of this group, those older than 18 were stratified by the presence of mental disorders. The two groups were those with mental disorders: 4,122 individuals representing a sample size of 4,789,634; and those without mental disorders: 30,312 individuals representing a sample size of 33,893,665. Based on our study, Hispanic patients with mental disorders were associated with lower HRQoL scores. SF-12 PCS scores (95% CI) were 45.3 (44.5, 46.1) for those with mental disorders and 50.8 (50.5, 51.0) for those without mental disorders. SF-12 MCS scores (95% CI) were 42.6 (42, 43.3) in patients with mental disorders and 52.6 (52.3, 52.8) in patients without mental disorders. These differences in scores denote the impact of mental health disorders on HRQoL scores in the Hispanic demographic and mark the way for further research on identifying means of improving such scores for Hispanic patients.

scholarly journals Modeling the Conditional Dependence between Discrete and Continuous Random Variables with Applications in Insurance

Mathematics ◽  
2020 ◽  
Vol 9 (1) ◽  
pp. 45
Author(s):  
Emilio Gómez-Déniz ◽  
Enrique Calderín-Ojeda
Keyword(s):  
Structural Model ◽  
Medical Expenditure Panel Survey ◽  
Health Care Use ◽  
Medical Expenditure ◽  
Panel Survey ◽  
Conditional Distributions ◽  
Conditional Dependence ◽  
Outpatient Visits ◽  
Conditional Expectations ◽  
The U.S

We jointly model amount of expenditure for outpatient visits and number of outpatient visits by considering both dependence and simultaneity by proposing a bivariate structural model that describes both variables, specified in terms of their conditional distributions. For that reason, we assume that the conditional expectation of expenditure for outpatient visits with respect to the number of outpatient visits and also, the number of outpatient visits expectation with respect to the expenditure for outpatient visits is related by taking a linear relationship for these conditional expectations. Furthermore, one of the conditional distributions obtained in our study is used to derive Bayesian premiums which take into account both the number of claims and the size of the correspondent claims. Our proposal is illustrated with a numerical example based on data of health care use taken from Medical Expenditure Panel Survey (MEPS), conducted by the U.S. Agency of Health Research and Quality.

scholarly journals Are There Racial Disparities in Psychotropic Drug Use and Expenditures in a Nationally Representative Sample of Men in the United States? Evidence From the Medical Expenditure Panel Survey

2013 ◽  
Vol 8 (1) ◽  
pp. 82-90 ◽  
Author(s):  
Geraldine Pierre ◽  
Roland J. Thorpe ◽  
Gniesha Y. Dinwiddie ◽  
Darrell J. Gaskin
Keyword(s):  
United States ◽  
Drug Use ◽  
Racial Disparities ◽  
Psychotropic Drug ◽  
Medical Expenditure Panel Survey ◽  
The United States ◽  
Medical Expenditure ◽  
Panel Survey ◽  
Psychotropic Drug Use ◽  
Nationally Representative

This article sought to determine whether racial disparities exist in psychotropic drug use and expenditures in a nationally representative sample of men in the United States. Data were extracted from the 2000-2009 Medical Expenditure Panel Survey, a longitudinal survey that covers the U.S. civilian noninstitutionalized population. Full-Year Consolidated, Medical Conditions, and Prescribed Medicines data files were merged across 10 years of data. The sample of interest was limited to adult males aged 18 to 64 years, who reported their race as White, Black, Hispanic, or Asian. This study employed a pooled cross-sectional design and a two-part probit generalized linear model for analyses. Minority men reported a lower probability of psychotropic drug use (Black = −4.3%, 95% confidence interval [CI] = [−5.5, −3.0]; Hispanic = −3.8%, 95% CI = [−5.1, −2.6]; Asian = −4.5%, 95% CI = [−6.2, −2.7]) compared with White men. After controlling for demographic, socioeconomic, and health status variables, there were no statistically significant race differences in drug expenditures. Consistent with previous literature, racial and ethnic disparities in the use of psychotropic drugs present problems of access to mental health care and services.

Sign in / Sign up

Export Citation Format

Share Document